These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 16319057)
41. TAp63gamma can substitute for p53 in inducing expression of the maspin tumor suppressor. Spiesbach K; Tannapfel A; Mössner J; Engeland K Int J Cancer; 2005 Apr; 114(4):555-62. PubMed ID: 15578720 [TBL] [Abstract][Full Text] [Related]
42. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Rocco JW; Leong CO; Kuperwasser N; DeYoung MP; Ellisen LW Cancer Cell; 2006 Jan; 9(1):45-56. PubMed ID: 16413471 [TBL] [Abstract][Full Text] [Related]
43. Transcriptional activity of TAp63 promoter is regulated by c-jun. Yao JY; Pao CC; Chen JK J Cell Physiol; 2010 Nov; 225(3):898-904. PubMed ID: 20607803 [TBL] [Abstract][Full Text] [Related]
44. Expression and regulation of the ΔN and TAp63 isoforms in salivary gland tumorigenesis clinical and experimental findings. Mitani Y; Li J; Weber RS; Lippman SL; Flores ER; Caulin C; El-Naggar AK Am J Pathol; 2011 Jul; 179(1):391-9. PubMed ID: 21703418 [TBL] [Abstract][Full Text] [Related]
45. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues. Muttray AF; Cox RL; Reinisch CL; Baldwin SA Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983 [TBL] [Abstract][Full Text] [Related]
46. p63 and p73: life and death in squamous cell carcinoma. Rocco JW; Ellisen LW Cell Cycle; 2006 May; 5(9):936-40. PubMed ID: 16687923 [TBL] [Abstract][Full Text] [Related]
47. deltaNp63alpha functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes. King KE; Ponnamperuma RM; Yamashita T; Tokino T; Lee LA; Young MF; Weinberg WC Oncogene; 2003 Jun; 22(23):3635-44. PubMed ID: 12789272 [TBL] [Abstract][Full Text] [Related]
48. TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression. Senoo M; Matsumura Y; Habu S Oncogene; 2002 Apr; 21(16):2455-65. PubMed ID: 11971180 [TBL] [Abstract][Full Text] [Related]
49. p63 overexpression induces the expression of Sonic Hedgehog. Caserta TM; Kommagani R; Yuan Z; Robbins DJ; Mercer CA; Kadakia MP Mol Cancer Res; 2006 Oct; 4(10):759-68. PubMed ID: 17050669 [TBL] [Abstract][Full Text] [Related]
50. DeltaNp63 isoforms differentially regulate gene expression in squamous cell carcinoma: identification of Cox-2 as a novel p63 target. Boldrup L; Coates PJ; Gu X; Nylander K J Pathol; 2009 Aug; 218(4):428-36. PubMed ID: 19391123 [TBL] [Abstract][Full Text] [Related]
51. p300 regulates p63 transcriptional activity. MacPartlin M; Zeng S; Lee H; Stauffer D; Jin Y; Thayer M; Lu H J Biol Chem; 2005 Aug; 280(34):30604-10. PubMed ID: 15965232 [TBL] [Abstract][Full Text] [Related]
52. DeltaNp63 regulates thymic development through enhanced expression of FgfR2 and Jag2. Candi E; Rufini A; Terrinoni A; Giamboi-Miraglia A; Lena AM; Mantovani R; Knight R; Melino G Proc Natl Acad Sci U S A; 2007 Jul; 104(29):11999-2004. PubMed ID: 17626181 [TBL] [Abstract][Full Text] [Related]
53. p63(TP63) elicits strong trans-activation of the MFG-E8/lactadherin/BA46 gene through interactions between the TA and DeltaN isoforms. Okuyama T; Kurata S; Tomimori Y; Fukunishi N; Sato S; Osada M; Tsukinoki K; Jin HF; Yamashita A; Ito M; Kobayashi S; Hata RI; Ikawa Y; Katoh I Oncogene; 2008 Jan; 27(3):308-17. PubMed ID: 17637751 [TBL] [Abstract][Full Text] [Related]
54. ΔNp63 silencing, DNA methylation shifts, and epithelial-mesenchymal transition resulted from TAp63 genome editing in squamous cell carcinoma. Katoh I; Tsukinoki K; Hata RI; Kurata SI Neoplasia; 2023 Nov; 45():100938. PubMed ID: 37778252 [TBL] [Abstract][Full Text] [Related]
55. GPX2, a direct target of p63, inhibits oxidative stress-induced apoptosis in a p53-dependent manner. Yan W; Chen X J Biol Chem; 2006 Mar; 281(12):7856-62. PubMed ID: 16446369 [TBL] [Abstract][Full Text] [Related]
56. Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors. Gunaratne PH; Pan Y; Rao AK; Lin C; Hernandez-Herrera A; Liang K; Rait AS; Venkatanarayan A; Benham AL; Rubab F; Kim SS; Rajapakshe K; Chan CK; Mangala LS; Lopez-Berestein G; Sood AK; Rowat AC; Coarfa C; Pirollo KF; Flores ER; Chang EH Cancer; 2019 Jul; 125(14):2409-2422. PubMed ID: 31012964 [TBL] [Abstract][Full Text] [Related]
57. SSRP1 functions as a co-activator of the transcriptional activator p63. Zeng SX; Dai MS; Keller DM; Lu H EMBO J; 2002 Oct; 21(20):5487-97. PubMed ID: 12374749 [TBL] [Abstract][Full Text] [Related]
58. DNA Demethylation Switches Oncogenic ΔNp63 to Tumor Suppressive TAp63 in Squamous Cell Carcinoma. Pokorna Z; Hrabal V; Tichy V; Vojtesek B; Coates PJ Front Oncol; 2022; 12():924354. PubMed ID: 35912167 [TBL] [Abstract][Full Text] [Related]
59. Evolutionarily conserved expression pattern and trans-regulating activity of Xenopus p51/p63. Tomimori Y; Katoh I; Kurata S; Okuyama T; Kamiyama R; Ikawa Y Biochem Biophys Res Commun; 2004 Jan; 313(2):230-6. PubMed ID: 14684151 [TBL] [Abstract][Full Text] [Related]